CATALOGO DEI PRODOTTI DELLA RICERCA

TARGHER, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.359
EU - Europa 16.259
AS - Asia 14.313
SA - Sud America 2.508
AF - Africa 296
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 27
Totale 53.801
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.121
GB - Regno Unito 6.807
SG - Singapore 5.859
CN - Cina 4.188
BR - Brasile 2.139
HK - Hong Kong 2.134
RU - Federazione Russa 1.600
FR - Francia 1.495
IE - Irlanda 1.281
IT - Italia 1.189
DE - Germania 1.119
SE - Svezia 971
FI - Finlandia 934
KR - Corea 568
VN - Vietnam 565
UA - Ucraina 359
ID - Indonesia 153
IN - India 133
AR - Argentina 119
CA - Canada 99
BD - Bangladesh 92
NL - Olanda 88
MX - Messico 87
JP - Giappone 83
TR - Turchia 78
EC - Ecuador 75
TG - Togo 72
AT - Austria 68
IQ - Iraq 60
BE - Belgio 59
ES - Italia 59
ZA - Sudafrica 57
IR - Iran 51
CO - Colombia 45
PL - Polonia 45
PK - Pakistan 42
AU - Australia 32
EG - Egitto 32
IL - Israele 30
PE - Perù 29
TW - Taiwan 29
MA - Marocco 28
PY - Paraguay 27
VE - Venezuela 27
AZ - Azerbaigian 26
UZ - Uzbekistan 25
SA - Arabia Saudita 24
CL - Cile 23
KE - Kenya 20
PH - Filippine 20
DZ - Algeria 17
GR - Grecia 17
TN - Tunisia 17
EU - Europa 16
JO - Giordania 16
LU - Lussemburgo 16
TH - Thailandia 16
LT - Lituania 15
AL - Albania 14
NG - Nigeria 14
CH - Svizzera 13
DK - Danimarca 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
KZ - Kazakistan 12
MY - Malesia 12
HU - Ungheria 11
JM - Giamaica 11
CZ - Repubblica Ceca 10
KG - Kirghizistan 10
PS - Palestinian Territory 10
RO - Romania 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
XK - ???statistics.table.value.countryCode.XK??? 9
BG - Bulgaria 7
LV - Lettonia 7
BY - Bielorussia 6
GE - Georgia 6
KH - Cambogia 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
NP - Nepal 6
PT - Portogallo 6
SN - Senegal 6
CY - Cipro 5
MK - Macedonia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
CR - Costa Rica 4
ET - Etiopia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
SI - Slovenia 4
VI - Stati Uniti Isole Vergini 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
Totale 53.711
Salva come PNG Salva come JPEG
Città #
Southend 6.313
Jacksonville 2.797
Dallas 2.777
Singapore 2.702
Chandler 2.278
Hong Kong 2.115
Woodbridge 1.759
Ann Arbor 1.275
Dublin 1.252
Houston 958
Ashburn 858
Beijing 637
Lawrence 571
Princeton 571
Wilmington 511
Nanjing 346
Jinan 332
Verona 315
Los Angeles 308
The Dalles 302
Buffalo 260
Helsinki 246
Shenyang 241
Columbus 216
Redondo Beach 211
Sindelfingen 209
New York 188
Ho Chi Minh City 175
Hebei 168
São Paulo 161
Munich 145
Santa Clara 137
Tianjin 131
Milan 127
Redmond 126
Guangzhou 115
Changsha 114
Nanchang 105
Seoul 98
Jiaxing 95
Haikou 92
Hanoi 92
Seattle 92
Zhengzhou 92
Ningbo 91
Hangzhou 85
Dong Ket 81
Jakarta 81
Lancaster 80
Norwalk 79
Turku 79
Rio de Janeiro 78
Taizhou 77
Lomé 72
Redwood City 70
Taiyuan 69
Tokyo 69
Council Bluffs 66
Chicago 65
Fairfield 65
Belo Horizonte 64
Moscow 64
Boardman 61
Washington 59
Nuremberg 57
Brussels 56
Shanghai 51
Brooklyn 50
Meda 47
Dongguan 45
London 45
Rome 45
Romola 41
Falls Church 40
San Francisco 40
Kent 39
Bologna 38
Wuhan 38
Lappeenranta 37
Brasília 35
Toronto 35
Mexico City 33
Vienna 33
Detroit 32
Amsterdam 31
Lanzhou 31
Porto Alegre 30
Baghdad 27
Montreal 27
Frankfurt am Main 26
Johannesburg 26
Warsaw 26
Baku 25
Lahore 25
Guayaquil 24
Quito 24
Atlanta 23
Boston 23
Campinas 23
Stockholm 23
Totale 35.319
Salva come PNG Salva come JPEG
Nome #
Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes 612
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? 590
Mortality from chronic liver diseases in diabetes 561
Severe hypoglycemia in patients with known diabetes requiring emergency department care: a report from an Italian multicenter study. 364
Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials 252
Abnormal liver enzymes in children and infants with COVID-19: A narrative review of case-series studies 228
STEATOEPATITE NON ALCOLICA E FIBROSI EPATICA IN UNA CASISTICA DI PAZIENTI OBESI SOTTOPOSTI A CHIRURGIA BARIATRICA 213
A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? [Review] 212
Biomarker Discovery for Metabolic Dysfunction-associated Steatotic Liver Disease Utilizing Mendelian Randomization, Machine Learning, and External Validation 203
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 201
Does high LDL-cholesterol cause cardiovascular disease? 200
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 185
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial). 173
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 163
ABO blood group, hypercoagulability, cardiovascular and cancer risk. [Review] 163
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. 159
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 156
Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women 154
A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. 153
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 148
Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes 144
Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. 143
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 142
Liver steatosis and its relation to plasma haemostatic factors in apparently healthy males. Role of the metabolic syndrome. 141
Relationship of fasting insulin to cardiovascular risk factor is already present in young men. The Verona Young Men Atherosclerosis Risk Factor Study. 140
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 139
25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. 135
Inter-atrial shunt inversion by the sitting position in a patient with a patent foramen ovale and acute pulmonary embolism. 135
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1581-P: "Nonalcoholic Fatty Liver Disease Is Associated with Heart Valve Calcification in Type 2 Diabetes" 135
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 135
Association between non-alcoholic fatty liver disease and decreased lung function in adults: a systematic review and meta-analysis 135
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. 134
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. 134
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes 134
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 132
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 131
Concordance between MAFLD and NAFLD diagnostic criteria in "real-world" data 131
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 130
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes 130
Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects. Relationship with insulin resistance. 129
Acquired factor VIII inhibitors in oncohematology: a systematic review. 129
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure 129
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes 128
"Not all forms of NAFLD were created equal". Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis? 128
NAFLD, diabete tipo 2, malattia cardiovascolare? 127
Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables. 126
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. 126
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring 126
25-hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. 125
Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women 124
Serum uric acid and related factors in 500 hospitalized subjects. 123
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 123
Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. 123
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 123
Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes 122
A fatty liver leads to decreased kidney function? 122
The white blood cell count:its relatioship to plasma insulin and other cardiovascular risk factors in healthy male 121
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 121
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 121
Psychological distress, Self-Efficacy and Glycemic Control in Type 2 Diabetes 121
Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia 120
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. 120
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus 118
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 118
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments 118
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring 117
Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides 117
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. 117
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 116
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 115
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 114
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 114
Anaphylaxis in patients with congenital bleeding disorders and inhibitors. [Review] 113
Increase in Circulating Products of Lipid Peroxidation in Smokers with IDDM. Diabetes Care 19: 1233-1236, 1996 112
Usefulness of Subclinical Left Ventricular Midwall Dysfunction to Predict Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus. 112
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes 112
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement 112
Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis 112
Pancreatic Fat Accumulation and Its Relationship with Liver Fat Content and Other Fat Depots in Obese Individuals. 111
Iperuricemia e rischio cardiovascolare. [Review] 111
Increased aortic stiffness in adults with chronic indeterminate Chagas disease 111
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 110
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 110
Does mild resistance training resemble a similar stimulus than aerobic training? - Authors' reply 110
Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients. 109
Hypovitaminosis D among unselected in-patients and out-patients in northern Italy. 109
Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure 109
Psoriasis and the metabolic syndrome 109
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. 108
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. [Review] 108
Predictors of estimated glomerular filtration rate decline in patients with type 2 diabetes and preserved kidney function. 108
Relationship of uric acid concentration to cardiovascular risk factors in healthy young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. 107
Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men. The European Fat Distribution Study. 107
Measurement of microvolt T-wave alternans, a new arrhythmic risk stratification test, in type 2 diabetic patients without clinical cardiovascular disease. 107
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis 107
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents 107
Inflammatory markers may mediate the link between low plasma vitamin B6 concentrations and cardiovascular disease in type 2 diabetes. 106
Interrelazioni tra acidi grassi di deposito in tessuto adiposo sottocutaneo, assetto lipidico ed attività fibrinolitica plasmatica. 106
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. 106
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 106
Totale 14.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.055
article - articoli 214.994
book - libri 0
conference - conferenze 476
curatela - curatele 0
other - altro 677
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.908
Totale 436.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.541 0 0 0 477 557 517 109 354 531 357 404 235
2021/20223.554 343 749 97 149 119 195 47 286 164 127 333 945
2022/20237.426 693 528 852 1.226 703 1.803 85 405 758 51 207 115
2023/20244.105 174 392 422 471 499 588 243 268 50 170 556 272
2024/202512.357 749 786 414 1.974 692 345 536 655 1.907 991 911 2.397
2025/20269.147 2.796 2.363 3.352 636 0 0 0 0 0 0 0 0
Totale 54.660